Autolus Therapeutics (AUTL) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Autolus Therapeutics (AUTL) over the last 6 years, with Q3 2025 value amounting to -$0.3.
- Autolus Therapeutics' EPS (Weighted Average and Diluted) rose 322.58% to -$0.3 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.83, marking a year-over-year increase of 3196.72%. This contributed to the annual value of -$0.86 for FY2024, which is 2793.37% up from last year.
- According to the latest figures from Q3 2025, Autolus Therapeutics' EPS (Weighted Average and Diluted) is -$0.3, which was up 322.58% from -$0.18 recorded in Q2 2025.
- Autolus Therapeutics' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.53 during Q1 2021, with a 5-year trough of -$466.29 in Q3 2021.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.26 (2023), whereas its average is -$24.9.
- As far as peak fluctuations go, Autolus Therapeutics' EPS (Weighted Average and Diluted) skyrocketed by 10000.18% in 2021, and later plummeted by 19787.23% in 2022.
- Quarter analysis of 5 years shows Autolus Therapeutics' EPS (Weighted Average and Diluted) stood at -$3.43 in 2021, then skyrocketed by 93.29% to -$0.23 in 2022, then plummeted by 95.65% to -$0.45 in 2023, then skyrocketed by 75.96% to -$0.11 in 2024, then plummeted by 177.29% to -$0.3 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.3 for Q3 2025, versus -$0.18 for Q2 2025 and -$0.26 for Q1 2025.